Total Payments
$186,788
2024 Payments
$36,779
Companies
52
Transactions
898
Medicare Patients
12,607
Medicare Billing
$541,536
Payment Breakdown by Category
Consulting$177,120 (94.8%)
Food & Beverage$9,668 (5.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $177,120 | 243 | 94.8% |
| Food and Beverage | $9,668 | 655 | 5.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| CSL Behring | $114,679 | 166 | $0 (2022) |
| CSL Plasma Inc. | $62,441 | 77 | $0 (2024) |
| PFIZER INC. | $1,118 | 89 | $0 (2024) |
| ABBVIE INC. | $897.44 | 64 | $0 (2024) |
| Novo Nordisk Inc | $892.58 | 65 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $869.98 | 40 | $0 (2024) |
| Lilly USA, LLC | $836.01 | 60 | $0 (2024) |
| Amgen Inc. | $628.54 | 53 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $408.99 | 27 | $0 (2024) |
| GlaxoSmithKline, LLC. | $398.78 | 29 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $36,779 | 136 | CSL Plasma Inc. ($35,105) |
| 2023 | $28,653 | 130 | CSL Plasma Inc. ($27,335) |
| 2022 | $28,360 | 137 | CSL Behring ($27,012) |
| 2021 | $22,688 | 123 | CSL Behring ($21,331) |
| 2020 | $23,644 | 98 | CSL Behring ($22,341) |
| 2019 | $16,567 | 79 | CSL Behring ($15,925) |
| 2018 | $12,130 | 76 | CSL Behring ($11,260) |
| 2017 | $17,966 | 119 | CSL Behring ($16,810) |
All Payment Transactions
898 individual payment records from CMS Open Payments — Page 1 of 36
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Seqirus USA Inc | Flucelvax (Biological), Fluad | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: Vaccines | ||||||
| 12/20/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $10.31 | General |
| Category: PAIN | ||||||
| 12/18/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $800.00 | General |
| 12/12/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $25.01 | General |
| Category: NEUROSCIENCE | ||||||
| 12/11/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $1,639.00 | General |
| 12/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: Gastroenterology | ||||||
| 12/11/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: Diabetes | ||||||
| 12/10/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $12.42 | General |
| Category: VACCINES | ||||||
| 12/04/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $800.00 | General |
| 12/03/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $28.55 | General |
| Category: UROLOGY | ||||||
| 12/02/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: NEUROSCIENCE | ||||||
| 11/27/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $1,639.20 | General |
| 11/27/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| 11/27/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| 11/20/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $1,200.00 | General |
| 11/17/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: VACCINES | ||||||
| 11/15/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: Respiratory | ||||||
| 11/13/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| 11/12/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $10.56 | General |
| Category: PAIN | ||||||
| 11/06/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $800.00 | General |
| 10/31/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $2.87 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: Obesity | ||||||
| 10/28/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $10.11 | General |
| Category: PAIN | ||||||
| 10/23/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $800.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 37 | 2,841 | 5,686 | $340,702 | $132,550 |
| 2022 | 40 | 3,108 | 6,794 | $350,376 | $146,600 |
| 2021 | 39 | 4,149 | 7,214 | $369,815 | $170,778 |
| 2020 | 32 | 2,509 | 4,815 | $232,619 | $91,608 |
Total Patients
12,607
Total Services
24,509
Medicare Billing
$541,536
Procedure Codes
148
All Medicare Procedures & Services
148 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 22 | 1,920 | $63,360 | $34,656 | 54.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 268 | 443 | $90,372 | $33,169 | 36.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 175 | 300 | $39,600 | $16,001 | 40.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 87 | 87 | $6,351 | $6,221 | 98.0% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 29 | 34 | $10,098 | $5,132 | 50.8% |
| 91322 | Sarscov2 vac 50 mcg/0.5ml im | Office | 2023 | 34 | 34 | $5,100 | $4,862 | 95.3% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 188 | 198 | $12,276 | $3,246 | 26.4% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 244 | 248 | $10,912 | $3,211 | 29.4% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 256 | 297 | $13,068 | $3,074 | 23.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 227 | 351 | $4,914 | $2,901 | 59.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 94 | 94 | $3,948 | $2,688 | 68.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 261 | 335 | $13,065 | $2,537 | 19.4% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 82 | 82 | $5,658 | $1,551 | 27.4% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 98 | 164 | $7,216 | $1,537 | 21.3% |
| 82306 | Vitamin d-3 level | Office | 2023 | 51 | 52 | $5,148 | $1,486 | 28.9% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 34 | 34 | $1,360 | $1,296 | 95.3% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 16 | 22 | $3,795 | $954.99 | 25.2% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 27 | 27 | $7,425 | $936.36 | 12.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 32 | 102 | $5,100 | $924.07 | 18.1% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 245 | 296 | $6,512 | $911.23 | 14.0% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 33 | 48 | $3,312 | $851.17 | 25.7% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 26 | 30 | $2,970 | $560.44 | 18.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 16 | 18 | $2,574 | $558.13 | 21.7% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 48 | 67 | $2,412 | $555.43 | 23.0% |
| 0134A | Adm sarscv2 bvl 50mcg/.5ml a | Office | 2023 | 11 | 11 | $484.00 | $419.32 | 86.6% |
About Dr. Kent Kiracofe, M.D
Dr. Kent Kiracofe, M.D is a Family Medicine healthcare provider based in Manhattan, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1285689380.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kent Kiracofe, M.D has received a total of $186,788 in payments from pharmaceutical and medical device companies, with $36,779 received in 2024. These payments were reported across 898 transactions from 52 companies. The most common payment nature is "Consulting Fee" ($177,120).
As a Medicare-enrolled provider, Kiracofe has provided services to 12,607 Medicare beneficiaries, totaling 24,509 services with total Medicare billing of $541,536. Data is available for 4 years (2020–2023), covering 148 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Manhattan, KS
- Active Since 05/24/2006
- Last Updated 07/25/2013
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1285689380
Products in Payments
- VRAYLAR (Drug) $549.53
- JARDIANCE (Drug) $379.08
- NURTEC ODT (Drug) $330.99
- TRULICITY (Drug) $305.75
- BREZTRI (Drug) $288.23
- UBRELVY (Drug) $270.40
- Ozempic (Drug) $249.59
- ELIQUIS (Drug) $231.87
- EVENITY (Biological) $221.29
- MOUNJARO (Drug) $221.18
- TRELEGY ELLIPTA (Drug) $213.61
- FARXIGA (Drug) $209.08
- Vascepa (Drug) $204.26
- PREVNAR 20 (Biological) $204.13
- Rybelsus (Drug) $195.08
- XIFAXAN (Drug) $182.75
- Otezla (Drug) $160.74
- Wegovy (Drug) $154.25
- QULIPTA (Drug) $148.88
- Saxenda (Drug) $143.65
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Manhattan
Bradley Harrison, M.d, M.D
Family Medicine — Payments: $451,744
Family Medicine $451,744
Dr. Kyle Platz, D.o, D.O
Family Medicine — Payments: $52,764
Family Medicine $52,764
Bethany Duff, Md, MD
Family Medicine — Payments: $8,727
Family Medicine $8,727
Dr. Cary Herl, Md, MD
Family Medicine — Payments: $8,424
Family Medicine $8,424
Dr. Jacqi Lambert, M.d, M.D
Family Medicine — Payments: $8,316
Family Medicine $8,316
Dr. Debra Doubek, M.d, M.D
Family Medicine — Payments: $6,497
Family Medicine $6,497